Expanding The Prescribing Rights of Pharmacists
Drug Topics
APRIL 19, 2023
Ned Milenkovich, PharmD, JD, joins the Spring 2023 Total Pharmacy Solutions Summit for a seminar on the history and future of prescribing rights within pharmacy.
Drug Topics
APRIL 19, 2023
Ned Milenkovich, PharmD, JD, joins the Spring 2023 Total Pharmacy Solutions Summit for a seminar on the history and future of prescribing rights within pharmacy.
PharmaVoice
APRIL 19, 2023
One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 19, 2023
Timothy Aungst, PharmD at The Digital Apothecary joined the April 2023 Total Pharmacy Solutions Summit and spoke about how technology and automation continue to grow in the health care world.
PhRMA
APRIL 19, 2023
PhRMA has awarded a $140,000 grant to the Emerson Diversity Health Foundation as part of our commitment to addressing health inequities and enhancing clinical trial diversity.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 19, 2023
Dr. Laura Faast joined the Spring 2023 Total Pharmacy Solutions Summit to talk about the best ways pharmacies can improve their cashflow.
PhRMA
APRIL 19, 2023
PhRMA ha otorgado una beca de 140.000 USD a la “ Emerson Diversity Health Foundation ” como parte de nuestro compromiso de enfrentar la desigualdad en la asistencia médica y aumentar la diversidad de los elegidos para ensayos clínicos.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
APRIL 19, 2023
Goodbye, original COVID-19 vaccines: FDA updates shot guidance, pulls monovalent authorizations zbecker Wed, 04/19/2023 - 11:04
Drug Topics
APRIL 19, 2023
Only the 60 mg dose of atogepant is approved for chronic migraine prevention.
Pharmacy Times
APRIL 19, 2023
Data from the aflibercept 8 mg clinical trial program will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, April 23 to 27.
Drug Topics
APRIL 19, 2023
Dean Koskinas, PharmD, is the Execute Sales Consultant at Transaction Data Systems. He joined the Spring 2023 TPSS to discuss the best ways to integrate technology into all aspects of a pharmacy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
APRIL 19, 2023
The US Food and Drug Administration (FDA) has made changes to the emergency use authorisations (EUAs) of the Pfizer -BioNTech and Moderna bivalent mRNA Covid-19 vaccines. The latest amendment aims to simplify the vaccination schedule for most people. The changes mean that the current bivalent vaccines for the original and Omicron BA.4/BA.5 strains can now be utilised for all doses administered to those aged six months and above.
Drug Topics
APRIL 19, 2023
Paige Clarke, RPh, and Billy Chow, RPh from Prescryptive Health join TPSS to discuss the role of the pharmacist in drug prices, and how to better serve the community.
Pharmacy Times
APRIL 19, 2023
Neurovascular mechanisms cause the decrease in BP levels, results from a study of 23 participants in Brazil show.
Drug Topics
APRIL 19, 2023
The expected PDUFA date is December 16, 2023.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
APRIL 19, 2023
A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.
Fierce Healthcare
APRIL 19, 2023
HIMSS23: Best Buy Health, VillageMD execs see collaboration as critical to future of healthcare agliadkovskaya Wed, 04/19/2023 - 15:15
Pharmacy Times
APRIL 19, 2023
Atypical respiratory syncytial virus epidemics may continue, and testing patients for multiple respiratory pathogens when indicated might be necessary.
STAT
APRIL 19, 2023
University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic diseases, and in 2008 — when she was on the faculty at the University of Pennsylvania — was hired as a Howard Hughes Medical Institute investigator, an honor for which she received $1 million a year over the next 12 years to further her research.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 19, 2023
HIMSS23: Athenahealth rolls out new tool to measure how well patients engage with digital health aburky Wed, 04/19/2023 - 16:23
Pharmacy Times
APRIL 19, 2023
Pharmacists must be involved in managing adverse effects and drug-drug interactions as psychedelic medicines collide with traditional psychiatric treatments.
Fierce Healthcare
APRIL 19, 2023
Elevance Health's profits rise 11% in Q1 to $2B pminemyer Wed, 04/19/2023 - 07:38
Pharmacy Times
APRIL 19, 2023
Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.
Fierce Healthcare
APRIL 19, 2023
How mobile health apps and self-monitoring enhance patient care mteefey Wed, 04/19/2023 - 12:47
Pharmacy Times
APRIL 19, 2023
Analysis shows that babies of mothers who used drugs while pregnant were shorter at birth and weighed less during the breastfeeding stage compared with non-drug-exposed infants.
European Pharmaceutical Review
APRIL 19, 2023
“The approval of Omisirge is a significant development in hematopoietic stem cell transplantation” Omisirge ® (omidubicel-onlv), now US Food and Drug Administration (FDA) approved , is the first allogeneic stem cell transplant therapy to be given marketing authorisation based on results from a global, randomised Phase III clinical study. The treatment is indicated for patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation, following myeloablati
Pharmacy Times
APRIL 19, 2023
The findings could inform revisions to safety guidelines and policies that help protect people with cardiovascular issues during heat waves.
Fierce Healthcare
APRIL 19, 2023
Industry Voices—4 health plan priorities in 2023 and beyond pminemyer Thu, 04/20/2023 - 00:21
Pharmacy Times
APRIL 19, 2023
Omidubicel-onlv therapy aims to quicken the recovery of neutrophils and reduce the risk of infection in patients with cancer.
Drug Store News
APRIL 19, 2023
Both facilities will support the company's medical segment, focusing on its U.S. medical products and distribution and at-Home Solutions businesses.
Pharmaceutical Technology
APRIL 19, 2023
SAB Biotherapeutics has received breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for SAB-176, an investigational immunotherapy to treat influenza. The newly granted status allows SAB to speed up the development and review of SAB-176, which is currently being studied for use in post-exposure prophylaxis for Type A and Type B influenza in high-risk patients, including those with anti-viral resistant strains.
Fierce Healthcare
APRIL 19, 2023
Bright Health on the hot seat — again — as SSM Health sues for $13M in unpaid claims pminemyer Wed, 04/19/2023 - 11:06
STAT
APRIL 19, 2023
An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule. The Advisory Committee on Immunization Practices was not asked to vote on the changes , announced Tuesday by the Food and Drug Administration.
Fierce Healthcare
APRIL 19, 2023
Bipartisan reps, hospitals back new bill delaying billions in DSH payment cuts to FY2026 dmuoio Wed, 04/19/2023 - 12:20
Let's personalize your content